Delivery Order SPE2DB25D3008-SPE2DB26FRBHP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) under a firm fixed-price contract. The order, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Scemblix 40 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order valued at $13,973.47, with an ultimate completion date of November 26, 2025. The award carries no set-aside designation and was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Scemblix 40 mg tablets (60-count unit doses) with a ceiling value of $13,259.50. This firm fixed-price delivery order, with an ultimate completion date of November 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $26,519.00 for 60 tablets of Scemblix 40 mg by the Defense Logistics Agency's Medical Supply Chain on August 6, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The ultimate completion date is set for August 27, 2025, with performance to occur...
- The Defense Logistics Agency awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for 60 units of Scemblix 40 mg tablets, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under the company's larger pharmaceutical supply relationship with the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Scemblix 40 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $53,038.00. The order is non-set-aside and competitively awarded, with an ultimate completion date of October 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $26,519.00 to AmerisourceBergen Drug Corp for supply of Scemblix 40 mg tablets (60 count) on September 5, 2025, with completion targeted for September 26, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Scemblix 40 mg tablets (60-count units) with a ceiling value of $26,519.00. This firm fixed-price delivery order, with an ultimate completion date of November 25, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Scemblix 40 mg tablets (60-count units) with a contract ceiling value of $39,778.50. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to the pharmaceutical distributor. The contract is set to be completed by September 17, 2025, and performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $80.8K firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Scemblix 40 mg tablets (60-unit packages). The contract is classified as non-set-aside and represents a competitive award. Performance will be executed from the awardee's Conshohocken, Pennsylvania location, with an ultimate completion date of October 20, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB26FRBHPDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,259.50 on November 6, 2025, for the supply of Scemblix 40 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for December 1, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to provide a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical federal medical procurement vendor through competitive awards with the Defense Logistics Agency and its Medical Supply Chain. The company's extensive portfolio of federal contracts demonstrates capability across multiple therapeutic domains, from specialty medications to vaccines and medical devices, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Scemblix, a neurological treatment medication, represents one of numerous competitively awarded transactions through the company's prime vendor contracts supporting military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 11/6/25 |